FDA Outlines Plans to Use Quality Metrics for Surveillance of Manufacturers

Using new authorities granted under FDASIA, FDA would remotely collect data that’s available for inspection and analyze it based on standardized quality metrics, enabling its inspectorate to see which plants to visit and why. The agency could mandate participation but instead is offering an incentive: the regulatory flexibility that it didn’t deliver in return for quality by design.